Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Pharma and OTC market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 7.0% during the forecast period.
This report presents the market size and development trends by detailing the Pharma and OTC market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Pharma and OTC market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Pharma and OTC industry and will help you to build a panoramic view of the industrial development.
Pharma and OTC Market, By Type:
Prevent Respiratory Infections
Antibacterial
Analgesia
Treatment of Skin Diseases
Other
Pharma and OTC Market, By Application:
Hospital
Clinic
Drug Store
Some of the leading players are as follows:
Sanofi S.A.
Boehringer Ingelheim
GlaxoSmithKline PLC
Bayer
Teva Pharmaceutical
Endo
Takeda
PGT Healthcare
Daiichi-Sankyo
Novartis International AG
Pfizer
Johnson & Johnson
Abbott
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Pharma and OTC Market: Technology Type Analysis
-
4.1 Pharma and OTC Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Pharma and OTC Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Prevent Respiratory Infections
4.3.2 Antibacterial
4.3.3 Analgesia
4.3.4 Treatment of Skin Diseases
4.3.5 Other
5 Pharma and OTC Market: Product Analysis
-
5.1 Pharma and OTC Product Market Share Analysis, 2018 & 2026
-
5.2 Pharma and OTC Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Pharma and OTC Market: Application Analysis
-
6.1 Pharma and OTC Application Market Share Analysis, 2018 & 2026
-
6.2 Pharma and OTC Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Hospital
6.3.2 Clinic
6.3.3 Drug Store
7 Pharma and OTC Market: Regional Analysis
-
7.1 Pharma and OTC Regional Market Share Analysis, 2018 & 2026
-
7.2 Pharma and OTC Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Sanofi S.A.
9.1.1 Sanofi S.A. Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Boehringer Ingelheim
9.2.1 Boehringer Ingelheim Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 GlaxoSmithKline PLC
9.3.1 GlaxoSmithKline PLC Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Bayer
9.4.1 Bayer Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Teva Pharmaceutical
9.5.1 Teva Pharmaceutical Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Endo
9.6.1 Endo Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Takeda
9.7.1 Takeda Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 PGT Healthcare
9.8.1 PGT Healthcare Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Daiichi-Sankyo
9.9.1 Daiichi-Sankyo Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Novartis International AG
9.10.1 Novartis International AG Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Pfizer
9.11.1 Pfizer Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Johnson & Johnson
9.12.1 Johnson & Johnson Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 Abbott
9.13.1 Abbott Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
The List of Tables and Figures (Totals 105 Figures and 147 Tables)
Figure Prevent Respiratory Infections Pharma and OTC market, 2015 - 2026 (USD Million)
Figure Antibacterial Pharma and OTC market, 2015 - 2026 (USD Million)
Figure Analgesia Pharma and OTC market, 2015 - 2026 (USD Million)
Figure Treatment of Skin Diseases Pharma and OTC market, 2015 - 2026 (USD Million)
Figure Other Pharma and OTC market, 2015 - 2026 (USD Million)
Figure Hospital market, 2015 - 2026 (USD Million)
Figure Clinic market, 2015 - 2026 (USD Million)
Figure Drug Store market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Pharma and OTC market, by country, 2015 - 2026 (USD Million)
-
Table North America Pharma and OTC market, by type, 2015 - 2026 (USD Million)
-
Table North America Pharma and OTC market, by product, 2015 - 2026 (USD Million)
-
Table North America Pharma and OTC market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Pharma and OTC market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Pharma and OTC market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Pharma and OTC market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Pharma and OTC market, by type, 2015 - 2026 (USD Million)
-
Table Canada Pharma and OTC market, by product, 2015 - 2026 (USD Million)
-
Table Canada Pharma and OTC market, by application, 2015 - 2026 (USD Million)
-
Table Europe Pharma and OTC market, by country, 2015 - 2026 (USD Million)
-
Table Europe Pharma and OTC market, by type, 2015 - 2026 (USD Million)
-
Table Europe Pharma and OTC market, by product, 2015 - 2026 (USD Million)
-
Table Europe Pharma and OTC market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Pharma and OTC market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Pharma and OTC market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Pharma and OTC market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Pharma and OTC market, by type, 2015 - 2026 (USD Million)
-
Table Germany Pharma and OTC market, by product, 2015 - 2026 (USD Million)
-
Table Germany Pharma and OTC market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Pharma and OTC market, by type, 2015 - 2026 (USD Million)
-
Table France Pharma and OTC market, by product, 2015 - 2026 (USD Million)
-
Table France Pharma and OTC market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Pharma and OTC market, by type, 2015 - 2026 (USD Million)
-
Table Italy Pharma and OTC market, by product, 2015 - 2026 (USD Million)
-
Table Italy Pharma and OTC market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Pharma and OTC market, by type, 2015 - 2026 (USD Million)
-
Table Spain Pharma and OTC market, by product, 2015 - 2026 (USD Million)
-
Table Spain Pharma and OTC market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Pharma and OTC market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Pharma and OTC market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Pharma and OTC market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Pharma and OTC market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Pharma and OTC market, by type, 2015 - 2026 (USD Million)
-
Table China Pharma and OTC market, by product, 2015 - 2026 (USD Million)
-
Table China Pharma and OTC market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Pharma and OTC market, by type, 2015 - 2026 (USD Million)
-
Table Japan Pharma and OTC market, by product, 2015 - 2026 (USD Million)
-
Table Japan Pharma and OTC market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Pharma and OTC market, by type, 2015 - 2026 (USD Million)
-
Table India Pharma and OTC market, by product, 2015 - 2026 (USD Million)
-
Table India Pharma and OTC market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Pharma and OTC market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Pharma and OTC market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Pharma and OTC market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Pharma and OTC market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Pharma and OTC market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Pharma and OTC market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Pharma and OTC market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Pharma and OTC market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Pharma and OTC market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Pharma and OTC market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Pharma and OTC market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Pharma and OTC market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Pharma and OTC market, by application, 2015 - 2026 (USD Million)
-
Table MEA Pharma and OTC market, by country, 2015 - 2026 (USD Million)
-
Table MEA Pharma and OTC market, by type, 2015 - 2026 (USD Million)
-
Table MEA Pharma and OTC market, by product, 2015 - 2026 (USD Million)
-
Table MEA Pharma and OTC market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Pharma and OTC market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Pharma and OTC market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Pharma and OTC market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Pharma and OTC market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Pharma and OTC market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Pharma and OTC market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Sanofi S.A. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GlaxoSmithKline PLC Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bayer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Teva Pharmaceutical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Endo Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Takeda Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table PGT Healthcare Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Daiichi-Sankyo Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis International AG Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pfizer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Abbott Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
